Related Experiment Videos
Shared HLA antigens in couples with 5 or more, compared to 3 or 4 consecutive recurrent miscarriages
1Division of Transplantation Immunology; Tissue typing lab, Sheba Medical Center, Tel Hashomer, Israel.
Summary
Human Leukocyte Antigen (HLA) sharing between couples does not predict consecutive recurrent miscarriages (CRM) or pregnancy outcomes. This study found no diagnostic value of HLA antigens in immunologically mediated abortions.
Area of Science:
- Immunogenetics
- Reproductive Immunology
Background:
- Consecutive recurrent miscarriages (CRM) are a complex reproductive issue.
- The role of Human Leukocyte Antigen (HLA) sharing in CRM is debated.
- Previous studies suggest limited association between HLA sharing and CRM.
Purpose of the Study:
- To investigate the association between HLA antigen sharing and CRM in couples with a high number of miscarriages.
- To determine if HLA sharing predicts the ability to develop anti-paternal antibodies (APA).
- To assess the impact of HLA sharing on pregnancy outcomes after immunotherapy.
Main Methods:
- Analysis of shared HLA class I and class II antigens in 425 couples with CRM.
- Assessment of HLA phenotype and antibody response.
- Comparison between groups with three or four, and five or more miscarriages.
Main Results:
- No significant difference in HLA antigen sharing was found between CRM groups and controls.
- No specific HLA antigen or phenotype was associated with CRM in either partner.
- HLA sharing did not influence APA development or subsequent pregnancy success post-immunization.
Conclusions:
- Class I and Class II HLA antigens are not diagnostic markers for immunologically mediated abortion.
- HLA antigen sharing does not predict the capacity to mount an antibody response.
- HLA sharing does not influence the outcome of subsequent pregnancies.